Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
跌打损伤软膏治疗软组织挫伤有效性和安全性的随机双盲、安慰剂对照、多中心Ⅱ期探索性临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II exploratory clinical trial on the efficacy and safety of bruises ointment in the treatment of soft tissue contusions
以“疼痛VAS评分”为主要疗效指标,采用随机、双盲单模拟、安慰剂对照、多中心临床试验设计,评价跌打损伤软膏用于治疗软组织挫伤(气滞血瘀证)的有效性和安全性的临床试验,并进行初步的剂量探索。
[Translation] Taking "pain VAS score" as the main efficacy index, a randomized, double-blind, single-dummy, placebo-controlled, multi-center clinical trial design was used to evaluate the efficacy and safety of bruises ointment for the treatment of soft tissue contusion (qi stagnation and blood stasis syndrome). Clinical trials for safety and preliminary dose exploration.
跌打损伤软膏治疗踝关节扭伤有效性和安全性的随机双盲、安慰剂对照、多中心Ⅱ期探索性临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase II exploratory clinical trial of the efficacy and safety of bruises ointment in the treatment of ankle sprains
以“疼痛VAS评分”为主要疗效指标,采用随机、双盲单模拟、安慰剂对照、多中心临床试验设计,评价跌打损伤软膏用于治疗踝关节扭伤(气滞血瘀证)的有效性和安全性的临床试验,并进行初步的剂量探索。
[Translation] Taking "Pain VAS score" as the main efficacy index, a randomized, double-blind, single-dummy, placebo-controlled, multi-center clinical trial design was used to evaluate the effectiveness of bruises ointment in the treatment of ankle sprains (Qi stagnation and blood stasis syndrome). and safety clinical trials, and conduct preliminary dose exploration.
100 Clinical Results associated with Yiwu Zhenwei Chinese Herbal Medicine Technology Development Co., Ltd.
0 Patents (Medical) associated with Yiwu Zhenwei Chinese Herbal Medicine Technology Development Co., Ltd.
100 Deals associated with Yiwu Zhenwei Chinese Herbal Medicine Technology Development Co., Ltd.
100 Translational Medicine associated with Yiwu Zhenwei Chinese Herbal Medicine Technology Development Co., Ltd.